BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21629246)

  • 1. Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro.
    Wu G; Yu F; Xiao Z; Xu K; Xu J; Tang W; Wang J; Song E
    Br J Cancer; 2011 Jun; 105(1):146-53. PubMed ID: 21629246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.
    Kong G; Zhang J; Zhang S; Shan C; Ye L; Zhang X
    PLoS One; 2011 May; 6(5):e19518. PubMed ID: 21573166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.
    Wei X; Tan C; Tang C; Ren G; Xiang T; Qiu Z; Liu R; Wu Z
    Cell Signal; 2013 May; 25(5):1037-43. PubMed ID: 23376496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes.
    Bandopadhyay M; Banerjee A; Sarkar N; Panigrahi R; Datta S; Pal A; Singh SP; Biswas A; Chakrabarti S; Chakravarty R
    BMC Cancer; 2014 Sep; 14():721. PubMed ID: 25260533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBX Protein-Induced Downregulation of microRNA-18a is Responsible for Upregulation of Connective Tissue Growth Factor in HBV Infection-Associated Hepatocarcinoma.
    Liu X; Zhang Y; Wang P; Wang H; Su H; Zhou X; Zhang L
    Med Sci Monit; 2016 Jul; 22():2492-500. PubMed ID: 27421245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3'-UTR region of CyclinD1.
    Fu X; Tan D; Hou Z; Hu Z; Liu G
    Int J Mol Sci; 2012; 13(7):8514-8539. PubMed ID: 22942717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of MicroRNA-145 Caused by Hepatitis B Virus X Protein Promotes Expression of CUL5 and Contributes to Pathogenesis of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Gao F; Sun X; Wang L; Tang S; Yan C
    Cell Physiol Biochem; 2015; 37(4):1547-59. PubMed ID: 26512974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack.
    Shan C; Zhang S; Cui W; You X; Kong G; Du Y; Qiu L; Ye L; Zhang X
    Carcinogenesis; 2011 Aug; 32(8):1190-7. PubMed ID: 21665888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBx elevates oncoprotein AEG-1 expression to promote cell migration by downregulating miR-375 and miR-136 in malignant hepatocytes.
    Zhao J; Wang W; Huang Y; Wu J; Chen M; Cui P; Zhang W; Zhang Y
    DNA Cell Biol; 2014 Oct; 33(10):715-22. PubMed ID: 25050974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
    Bai PS; Xia N; Sun H; Kong Y
    J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
    Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
    Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
    Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
    Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
    Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
    Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
    Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.